PPARGC1A and cardiomyopathy: Collectively, these data illustrate a new protective mechanism for proper mitochondrial functions by Erk5 positive regulation of Pgc-1α, thus giving solid credence to the possibility of sustaining Erk5 integrity as a therapeutic approach for treating metabolic stress-induced cardiomyopathy.